ClearPoint Neuro, Inc. Common Stock (CLPT) Stock Price

CLPTStock

$15.55+48.24%52W

Market Cap$474.34M

P/E—

PEG Ratio0.61

Div yield—

Beta1.23

CLPT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-5.06%

Price vs S&P 500 (4W)-0.44%

PEG Ratio0.61

VGM Score58.03

Book Value / Share (Quarterly)$0.63

P/TBV (Annual)28.87x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)21.62%

Cash Flow / Share (Quarterly)$-0.89

Price vs S&P 500 (YTD)0.85%

Gross Margin (TTM)62.33%

Net Profit Margin (TTM)-71.57%

EPS (TTM)$-1.01

10-Day Avg Trading Volume0.51M

EPS Excl Extra (TTM)$-1.01

Revenue Growth (5Y)23.57%

EPS (Annual)$-0.90

ROI (Annual)-33.13%

Gross Margin (Annual)61.38%

Net Profit Margin (5Y Avg)-77.99%

Cash / Share (Quarterly)$1.19

Revenue Growth QoQ (YoY)42.93%

ROA (Last FY)-26.13%

Revenue Growth TTM (YoY)25.99%

EBITD / Share (TTM)$-0.89

ROE (5Y Avg)-68.81%

Operating Margin (TTM)-65.20%

Cash Flow / Share (Annual)$-0.83

P/B Ratio25.01x

P/B Ratio (Quarterly)14.48x

Net Income / Employee (Annual)$-148,500

EV / Revenue (TTM)11.95x

Net Interest Coverage (TTM)-20.69x

ROA (TTM)-36.98%

EPS Incl Extra (Annual)$-0.90

Current Ratio (Annual)5.91x

Quick Ratio (Quarterly)4.75x

3-Month Avg Trading Volume0.68M

52-Week Price Return48.24%

Revenue / Employee (TTM)$236,100

Tangible BV / Share (Quarterly)$0.18

P/S Ratio (Annual)12.74x

Asset Turnover (Annual)0.38x

52-Week High$30.10

Operating Margin (5Y Avg)-76.68%

EPS Excl Extra (Annual)$-0.90

CapEx CAGR (5Y)1.69%

Tangible BV CAGR (5Y)47.34%

26-Week Price Return6.87%

Quick Ratio (Annual)4.94x

13-Week Price Return27.04%

Total Debt / Equity (Annual)1.75x

Current Ratio (Quarterly)5.79x

Enterprise Value$485.19M

Revenue / Share Growth (5Y)10.03%

Asset Turnover (TTM)0.52x

Book Value / Share Growth (5Y)46.87%

Revenue / Employee (Annual)$214,900

Inventory Turnover (Annual)1.88x

Pretax Margin (Annual)-68.93%

Cash / Share (Annual)$1.56

3-Month Return Std Dev87.44%

Gross Margin (5Y Avg)62.85%

Net Income / Employee (TTM)$-169,000

ROE (Last FY)-91.15%

Net Interest Coverage (Annual)-11.31x

EPS Basic Excl Extra (Annual)$-0.90

Receivables Turnover (TTM)5.80x

Total Debt / Equity (Quarterly)2.63x

EPS Incl Extra (TTM)$-1.01

Receivables Turnover (Annual)6.17x

ROI (TTM)-48.60%

P/S Ratio (TTM)11.60x

Pretax Margin (5Y Avg)-77.95%

Revenue / Share (Annual)$1.31

Tangible BV / Share (Annual)$0.48

Price vs S&P 500 (52W)29.68%

Year-to-Date Return13.67%

5-Day Price Return2.50%

EPS Normalized (Annual)$-0.90

ROA (5Y Avg)-35.55%

Net Profit Margin (Annual)-69.08%

Month-to-Date Return4.08%

Cash Flow / Share (TTM)$-0.87

EBITD / Share (Annual)$-0.85

Operating Margin (Annual)-65.36%

LT Debt / Equity (Annual)1.75x

ROI (5Y Avg)-47.67%

LT Debt / Equity (Quarterly)2.63x

EPS Basic Excl Extra (TTM)$-1.01

P/TBV (Quarterly)50.33x

P/B Ratio (Annual)14.52x

Inventory Turnover (TTM)2.02x

Pretax Margin (TTM)-71.46%

Book Value / Share (Annual)$0.95

Price vs S&P 500 (13W)25.09%

Beta1.23x

P/FCF (Annual)74.67x

Revenue / Share (TTM)$1.37

ROE (TTM)-140.96%

52-Week Low$8.27

vGradeF

gGradeA

mGradeB

vgmGradeC

CLPT Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 3, 2026	-$0.29	-$0.38	-32.56%(-$0.09)
Q1 2026	May 13, 2026	-$0.27	-$0.32	-17.07%(-$0.05)
Q4 2025	Mar 17, 2026	-$0.20	-$0.27	-35.00%(-$0.07)
Q3 2025	Nov 6, 2025	-$0.20	-$0.21	-5.00%(-$0.01)
Q2 2025	Aug 12, 2025	-$0.20	-$0.21	-5.00%(-$0.01)

CLPT Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.13

4.22

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$15.55
SYKStryker Corporation	C	B	C	$330.69
MMM3M Company	C	D	C	$174.34
BSXBoston Scientific Corp.	C	B	D	$46.84
BDXBecton, Dickinson and Co.	B	D	B	$189.52
MDLNMedline Inc. Class A common stock	C	D	C	$35.28
RMDResMed Inc.	C	B	B	$240.33
DXCMDexCom, Inc.	D	B	B	$90.82
WSTWest Pharmaceutical Services, Inc.	D	C	B	$337.47
SOLVSolventum Corporation	C	C	B	$91.12
BAXBaxter International Inc.	B	D	B	$26.13
PENPenumbra, Inc.	D	C	C	$321.68
GMEDGLOBUS MEDICAL INC	B	B	C	$82.97
GKOSGlaukos Corporation	F	A	A	$179.87
PODDInsulet Corporation	C	A	C	$145.13
TFXTeleflex Incorporated	B	F	B	$139.67
STVNStevanato Group S.p.A.	D	C	C	$21.03
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$20.10
MMSIMerit Medical Systems Inc	C	B	B	$90.49
HAEHaemonetics Corporation	C	C	A	$103.96
ICUIICU Medical Inc	C	D	B	$175.10
HTFLHeartflow, Inc. Common Stock	—	A	B	$47.78
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$120.25
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$47.57
ATRCAtriCure, Inc.	D	B	B	$48.54
UFPTUFP Technologies Inc	C	B	B	$300.05
NVCRNovoCure Limited Ordinary Shares	D	C	B	$17.82
LMATLeMaitre Vascular, Inc.	C	B	C	$80.45
INSPInspire Medical Systems, Inc.	B	B	B	$61.44
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$25.64
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.43
ATECAlphatec Holdings, Inc.	D	B	C	$9.44
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.64
IARTIntegra LifeSciences Holdings	B	D	B	$16.89
AORTArtivion, Inc.	C	C	C	$26.77
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$20.83
IRMDiRadimed Corporation	D	B	C	$87.07
BVSBioventus Inc. Class A Common Stock	B	C	A	$13.84
BBNXBeta Bionics, Inc. Common Stock	D	A	B	$19.72
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.42
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.21
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.48
MDXGMiMedx Group, Inc	C	D	C	$4.50
ANGOAngioDynamics, Inc.	C	D	A	$15.85
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$23.65
BWAYBrainsway Ltd. American Depositary Shares	F	A	B	$14.30
DCTHDelcath Systems Inc	D	B	A	$16.34
CERSCerus Corp	D	C	B	$2.65
TCMDTactile Systems Technology, Inc.	B	B	C	$23.16
NPCENeuropace, Inc. Common Stock	D	C	B	$14.41
SGHTSight Sciences, Inc. Common Stock	D	B	A	$8.55

About ClearPoint Neuro, Inc. Common Stock

ClearPoint Neuro develops and commercializes minimally invasive surgical platforms for brain and cardiac procedures guided by real-time MRI imaging. The company's flagship ClearPoint system is currently in commercial use and addresses a significant market need for precise, image-guided neurosurgery. Revenue is generated through system sales, services, disposables, and software solutions.